Diagnosis and Management of Hereditary Hemochromatosis

Elizabeth Cabrera; Gonzalo Crespo; Lisa B VanWagner

doi:10.1001/jama.2022.17727

Diagnosis and Management of Hereditary Hemochromatosis

JAMA. 2022 Nov 8;328(18):1862-1863. doi: 10.1001/jama.2022.17727.

Authors

Elizabeth Cabrera¹, Gonzalo Crespo², Lisa B VanWagner³

Affiliations

¹ Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
² Liver Unit, Hospital Clinic, IDIBAPS, CIBERehd, University of Barcelona, Spain.
³ Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas.

PMID: 36346422
DOI: 10.1001/jama.2022.17727

No abstract available

Plain language summary

This JAMA Insights Clinical Review discusses the diagnosis and management of hereditary hemochromatosis, including clinical and laboratory characteristics, gene testing and interpretation, and the role of imaging and liver biopsy.

MeSH terms

Hemochromatosis Protein
Hemochromatosis* / diagnosis
Hemochromatosis* / genetics
Hemochromatosis* / therapy
Humans
Liver

Substances

Hemochromatosis Protein